Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for Breast Cancer Prevention (NSABP P-1)
NCT00000529Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- May 1992
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tamoxifen in breast cancer, sponsored by NSABP Foundation. Started May 1992; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00000529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000529.